Posts Tagged ‘Yaab’

Santarus stock soars on rights to diabetes drug – Reuters – 564th Edition

Friday, September 10th, 2010


Proactive Investors USA & Canada
Santarus stock soars on rights to diabetes drug
Reuters
N), exposing its heartburn drug Zegerid to generic competition. Samimy said Cycloset and Glumetza together could contribute $350-$400 million in peak sales
Santarus buys license to make diabetes drug for $5 mlnReuters

all 56 news articles »

By news.google.com
Yaab

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Tags: , , , , , , , , , , , , , , , , , , , , ,
Posted in Heartburn Remedies | No Comments »


Heartburn or heart trouble: What you body is saying – Helium – 563th Edition

Wednesday, September 8th, 2010

Heartburn or heart trouble: What you body is saying
Helium
An attack of heartburn can be more than uncomfortable; it can be down right painful. That burning sensation below your breastbone
The Dangers of Acid RefluxWVNS-TV

all 7 news articles »

By news.google.com
Yaab

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Tags: , , , , , , , , , , , , ,
Posted in Heartburn Remedies | No Comments »


A look at health risks associated with the overuse of heartburn blockers – Helium – 562th Edition

Tuesday, September 7th, 2010

A look at health risks associated with the overuse of heartburn blockers
Helium
With commercials all over the web and on televisions, it's not surprising that more and more Americans are using heartburn remedies.

By news.google.com
Yaab

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

Tags: , , , , , , , , ,
Posted in Heartburn Remedies | No Comments »